Literature DB >> 11688458

Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients.

K Kaserer1, C Scheuba, N Neuhold, A Weinhäusel, O A Haas, H Vierhapper, B Niederle.   

Abstract

By means of calcitonin screening programs, sporadic and hereditary medullary thyroid carcinoma (MTC) can be detected at an early stage. We investigated the histopathologic findings of 16 familial (mean age 32 +/- 21 years, female/male ratio 1.6:1) and 34 sporadic (mean age 58 +/- 15 years; female/male ratio 2.4:1) MTCs with stage T1 comparatively. Patients with hereditary tumors were younger. Hereditary tumors were more often found multifocal (13 of 16 vs 3 of 34; p < 0.001), bilateral (11 of 16 vs 3 of 34; p < 0.001), displaying desmoplastic stroma (14 of 16 vs 19 of 34; p = 0.02), and accompanied by C cell hyperplasia (16 of 16 vs 24 of 34; p = 0.01), but all of these factors were present in some sporadic patients. Only tumors with desmoplastic stroma showed lymph node metastasis, which was observed in eight of the 50 patients. After surgery all patients showed permanent normalization of calcitonin levels. We conclude that 1) morphologic parameters considered to indicate familial MTC risk are of no value in the individual patient, 2) many sporadic MTCs develop on the background of CCH, 3) tumors with desmoplastic stroma are more likely to develop lymph node metastasis, and 4) early detection of MTC permits curative surgery in the majority of patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11688458     DOI: 10.1097/00000478-200110000-00004

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  28 in total

1.  Sporadic medullary thyroid carcinoma with a pedunculated intraluminal internal jugular vein recurrence: A case report and literature review.

Authors:  Darren K Patten; Rashpal Flora; Neil Tolley; Fausto Palazzo
Journal:  Int J Surg Case Rep       Date:  2011-11-22

2.  Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia.

Authors:  Enrico Saggiorato; Ida Rapa; Francesca Garino; Gianni Bussolati; Fabio Orlandi; Mauro Papotti; Marco Volante
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

Review 3.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

4.  Isthmus-preserving total bilobectomy: an adequate operation for C-cell hyperplasia.

Authors:  Robert Arnulf Wahl; Christian Vorländer; Susanne Kriener; Johanna Pedall; Martin Spitza; Martin-Leo Hansmann
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

5.  Desmoplastic stromal reaction in medullary thyroid cancer-an intraoperative "marker" for lymph node metastases.

Authors:  Christian Scheuba; Klaus Kaserer; Klaus Kaczirek; Reza Asari; Bruno Niederle
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

Review 6.  Evolving molecularly targeted therapies for advanced-stage thyroid cancers.

Authors:  Keith C Bible; Mabel Ryder
Journal:  Nat Rev Clin Oncol       Date:  2016-03-01       Impact factor: 66.675

Review 7.  C-cell hyperplasia and medullary thyroid microcarcinoma.

Authors:  J A Albores-Saavedra; J E Krueger
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 8.  [Thyroid C cells and their pathology: Part 2: Medullary thyroid carcinoma].

Authors:  S Synoracki; S T Schmid; S Ting; K W Schmid
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

9.  Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).

Authors:  Bruno Niederle; Frédéric Sebag; Michael Brauckhoff
Journal:  Langenbecks Arch Surg       Date:  2013-12-03       Impact factor: 3.445

10.  Androgen receptor expression in C-cells and in medullary thyroid carcinoma.

Authors:  Qi-Hui Zhai; Katharina Ruebel; Geoffrey B Thompson; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.